Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mikel Larzabal is active.

Publication


Featured researches published by Mikel Larzabal.


BMC Gastroenterology | 2008

Resveratrol inhibits nonalcoholic fatty liver disease in rats

Luis Bujanda; Elizabeth Hijona; Mikel Larzabal; Marta Beraza; P. Aldazabal; Nerea García-Urkia; Cristina Sarasqueta; Angel Cosme; Belen Irastorza; Alberto Bradshaw Gonzalez; Juan Arenas

BackgroundThe prevalence of nonalcoholic fatty liver disease (NAFLD) is high. NAFLD is linked to obesity, diabetes mellitus, and hypertriglyceridemia. Approximately 20% of patients with NAFLD will eventually develop cirrhosis. Our purpose was to investigate whether resveratrol decreased hepatic steatosis in an animal model of steatosis, and whether this therapeutic approach resulted in a decrease in tumor necrosis factor α (TNF-α) production, lipid peroxidation and oxidative stress.MethodsMale Wistar CRL: Wi (Han) (225 g) rats were randomized into three groups. A control group (n = 12) was given free access to regular dry rat chow for 4 weeks. The steatosis (n = 12) and resveratrol (n = 12) groups were given free access to feed (a high carbohydrate-fat free modified diet) and water 4 days per week, and fasted for the remaining 3 days for 4 weeks. Rats in the resveratrol group were given resveratrol 10 mg daily by the oral route. All rats were killed at 4 weeks and assessed for fatty infiltration and bacterial translocation. Levels of TNF-α in serum, hepatic malondialdehyde (MDA), oxidative stress (superoxide dismutase, glutathione peroxidase, catalase and nitric oxide synthase) and biochemical parameters were measured.ResultsFat deposition was decreased in the resveratrol group as compared to the steatosis group (Grade 1 vs Grade 3, P < 0.05). TNF-α and MDA levels were significantly increased in the steatosis group (TNF-α; 33.4 ± 5.2 vs 26.24 ± 3.47 pg/ml and MDA; 9.08 ± 0.8 vs 3.17 ± 1.45 μM respectively, P < 0.05). This was accompanied by increased superoxide dismutase, glutathione peroxidase and catalase and decreased nitric oxide synthase in the liver of resveratrol group significantly (P < 0.05 vs steatosis group). Bacterial translocation was not found in any of the groups. Glucose levels were decreased in the group of rats given resveratrol (P < 0.05).ConclusionResveratrol decreased NAFLD severity in rats. This effect was mediated, at least in part, by TNF-α inhibition and antioxidant activities.


Clinical Cancer Research | 2010

MSH6 and MUTYH Deficiency Is a Frequent Event in Early-Onset Colorectal Cancer

María Dolores Giráldez; Francesc Balaguer; Luis Bujanda; Miriam Cuatrecasas; Jenifer Muñoz; Virginia Alonso-Espinaco; Mikel Larzabal; Anna Petit; Victoria Gonzalo; Teresa Ocaña; Leticia Moreira; José M. Enríquez-Navascués; C. Richard Boland; Ajay Goel; Antoni Castells; Sergi Castellví-Bel

Purpose: Early-onset colorectal cancer (CRC) is suggestive of a hereditary predisposition. Lynch syndrome is the most frequent CRC hereditary cause. The MUTYH gene has also been related to hereditary CRC. A systematic characterization of these two diseases has not been reported previously in this population. Experimental Design: We studied a retrospectively collected series of 140 patients ≤50 years old diagnosed with nonpolyposis CRC. Demographic, clinical, and familial features were obtained. Mismatch repair (MMR) deficiency was determined by microsatellite instability (MSI) analysis, and immunostaining for MLH1, MSH2, MSH6, and PMS2 proteins. Germline MMR mutations were evaluated in all MMR-deficient cases. Tumor samples with loss of MLH1 or MSH2 protein expression were analyzed for somatic methylation. Germline MUTYH mutations were evaluated in all cases. BRAF V600E and KRAS somatic mutational status was also determined. Results: Fifteen tumors (11.4%) were MSI, and 20 (14.3%) showed loss of protein expression (7 for MLH1/PMS2, 2 for isolated MLH1, 3 for MSH2/MSH6, 7 for isolated MSH6, and 1 for MSH6/PMS2). We identified 11 (7.8%) germline MMR mutations, 4 in MLH1, 1 in MSH2, and 6 in MSH6. Methylation analysis revealed one case with somatic MLH1 methylation. Biallelic MUTYH mutations were detected in four (2.8%) cases. KRAS and BRAF V600E mutations were present in 39 (27.9%) and 5 (3.6%) cases, respectively. Conclusions: Loss of MSH6 expression is the predominant cause of MMR deficiency in early-onset CRC. Our findings prompt the inclusion of MSH6 and MUTYH screening as part of the genetic counseling of these patients and their relatives. Clin Cancer Res; 16(22); 5402–13. ©2010 AACR.


BMC Gastroenterology | 2006

Effect of resveratrol on alcohol-induced mortality and liver lesions in mice

Luis Bujanda; María García-Barcina; Virginia Gutiérrez-de Juan; Joseba Bidaurrazaga; Marian Fernández de Luco; Marian Gutiérrez-Stampa; Mikel Larzabal; Elisabeth Hijona; Cristina Sarasqueta; Miguel Echenique-Elizondo; Juan Arenas

BackgroundResveratrol is a polyphenol with important antiinflammatory and antioxidant properties. We investigated the effect of resveratrol on alcohol-induced mortality and liver lesions in mice.MethodsMice were randomly distributed into four groups (control, resveratrol-treated control, alcohol and resveratrol-treated alcohol). Chronic alcohol intoxication was induced by progressively administering alcohol in drinking water up to 40% v/v. The mice administered resveratrol received 10 mg/ml in drinking water. The animals had free access to standard diet. Blood levels were determined for transaminases, IL-1 and TNF-α. A histological evaluation was made of liver damage, and survival among the animals was recorded.ResultsTransaminase concentration was significantly higher in the alcohol group than in the rest of the groups (p < 0.05). IL-1 levels were significantly reduced in the alcohol plus resveratrol group compared with the alcohol group (p < 0.05). TNF-α was not detected in any group. Histologically, the liver lesions were more severe in the alcohol group, though no significant differences between groups were observed. Mortality in the alcohol group was 78% in the seventh week, versus 22% in the alcohol plus resveratrol group (p < 0.001). All mice in the alcohol group died before the ninth week.ConclusionThe results obtained suggest that resveratrol reduces mortality and liver damage in mice.


BMC Medicine | 2014

Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery.

Raúl Jiménez-Agüero; José Ignacio Emparanza; Adolfo Beguiristain; Luis Bujanda; José Antonio Mujika Alustiza; Elisabeth García; Elizabeth Hijona; Lander Gallego; Javier Sánchez-González; M.J. Perugorria; José Ignacio Asensio; Santiago Larburu; Maddi Garmendia; Mikel Larzabal; María P. Portillo; Leixuri Aguirre; Jesus M. Banales

BackgroundNon-alcoholic fatty liver disease (NAFLD) is caused by abnormal accumulation of lipids within liver cells. Its prevalence is increasing in developed countries in association with obesity, and it represents a risk factor for non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. Since NAFLD is usually asymptomatic at diagnosis, new non-invasive approaches are needed to determine the hepatic lipid content in terms of diagnosis, treatment and control of disease progression. Here, we investigated the potential of magnetic resonance imaging (MRI) to quantitate and monitor the hepatic triglyceride concentration in humans.MethodsA prospective study of diagnostic accuracy was conducted among 129 consecutive adult patients (97 obesity and 32 non-obese) to compare multi-echo MRI fat fraction, grade of steatosis estimated by histopathology, and biochemical measurement of hepatic triglyceride concentration (that is, Folch value).ResultsMRI fat fraction positively correlates with the grade of steatosis estimated on a 0 to 3 scale by histopathology. However, this correlation value was stronger when MRI fat fraction was linked to the Folch value, resulting in a novel equation to predict the hepatic triglyceride concentration (mg of triglycerides/g of liver tissue = 5.082 + (432.104 * multi-echo MRI fat fraction)). Validation of this formula in 31 additional patients (24 obese and 7 controls) resulted in robust correlation between the measured and estimated Folch values. Multivariate analysis showed that none of the variables investigated improves the Folch prediction capacity of the equation. Obese patients show increased steatosis compared to controls using MRI fat fraction and Folch value. Bariatric surgery improved MRI fat fraction values and the Folch value estimated in obese patients one year after surgery.ConclusionsMulti-echo MRI is an accurate approach to determine the hepatic lipid concentration by using our novel equation, representing an economic non-invasive method to diagnose and monitor steatosis in humans.


Cirugia Espanola | 2014

Características fenotípicas de los pacientes con síndrome de poliposis serrada de colon: estudio de 23 casos

Garazi Elorza; José M. Enríquez-Navascués; Luis Bujanda; Mikel Larzabal; Inés Gil Lasa; Laura Martí

INTRODUCTION Serrated polyposis syndrome (SPS) is a rare entity characterized by the presence of multiple hyperplastic polyps in the colon and an increased risk of presentation and development of colorectal cancer (CRC). OBJECTIVE To evaluate the clinical and phenotypical characteristics of patients that present one of the 3 WHO criteria for the diagnosis of SPS diagnosed and treated a tour hospital. PATIENTS AND METHODS Patients with the diagnosis of SPS during 2005-2012 were revised; 24.208 colonoscopies were performed during this period. Age, sex, family history of CRC (APC/MYH), proximal/mixed/distal phenotype, indication for colonoscopy, number, size, location of the hyperplastic polyps, presence of mixed/adenomatous polyps, CRCI, follow-up and endoscopio/surgical treatment. RESULTS A total of 23 cases were included (19 male). The median age was 51. A total of 34% had a prior family history of CRC or polpyps. Distal phenotype was more frequent (48%). Another 73% presented synchronous adenomatous polyps, and 26% a CRC. A total of 57% were asymptomatic. Surgery was performed in 9 cases (6 for cancer and 3 for polyposis), and 14 were treated by polypectomy and observation. Eleven patients (47%) presented recurrent/persistent lesions after initial surgical/endoscopic treatment. CONCLUSION SPS is an heterogeneous syndrome that is variable in the type, size, distribution and number of polyps, and is more common in male smokers with a distal phenotype. The majority of patients also present synchronous adenomatous polyps. These patients require an organized multidisciplinary evaluation.


Revista Espanola De Enfermedades Digestivas | 2011

Diagnosis of Whipple's disease using molecular biology techniques

Angel Cosme; Evelia Ojeda; Ana I. Muñagorri; Eduardo Gaminde; Luis Bujanda; Mikel Larzabal; Inés Gil

The diagnosis of Whipples disease (WD) is based on the existence of clinical signs and symptoms compatible with the disease and in the presence of PAS-positive diastase-resistant granules in the macrophages of the small intestine. If there is suspicion of the disease but no histological findings or only isolated extraintestinal manifestations, species-specific PCR using different sequences of the T. whippleii genome from different tissue types and biological fluids is recommended.This study reports two cases: the first patient had diarrhea and the disease was suspected after an endoscopic examination of the ileum, while the second patient had multi-systemic manifestations,particularly abdominal, thoracic, and peripheral lymphadenopathies. In both cases, the diagnosis was confirmed using molecular biology techniques to samples from the small intestine or from a retroperineal lymph node, respectively.


World Journal of Gastroenterology | 2010

Biochemical determination of lipid content in hepatic steatosis by the Soxtec method

Elizabeth Hijona; Lander Hijona; Mikel Larzabal; Cristina Sarasqueta; P. Aldazabal; Juan Arenas; Luis Bujanda


Digestive Diseases and Sciences | 2015

Diagnostic Performance of Fecal Immunochemical Test and Sigmoidoscopy for Advanced Right-Sided Colorectal Neoplasms

Inés Castro; Pamela Estévez; Joaquín Cubiella; Vicent Hernandez; Carmen González-Mao; Concepción Rivera; Felipe Iglesias; Lucía Cid; Santiago Soto; Luisa De-Castro; Pablo Vega; Jose Antonio Hermo; Ramiro Macenlle; Alfonso Martínez; Estela Cid; Inés Gil; Mikel Larzabal; Luis Bujanda; Antoni Castells


Cirugia Espanola | 2014

Phenotype Characteristics of Patients With Colonic Serrated Polyposis Syndrome: A Study of 23 Cases ☆

Garazi Elorza; José M. Enríquez-Navascués; Luis Bujanda; Mikel Larzabal; Inés Gil Lasa; Laura Martí


Revista Espanola De Enfermedades Digestivas | 2011

Diagnóstico, tratamiento y seguimiento de los tumores carcinoides del estómago: Estudio de 14 casos

Alazne Aguirre; Angel Cosme; Luis Bujanda; Jose María Enríquez Navascués; Santiago Larburu; Mikel Larzabal; Inés Gil; José Ignacio Asensio

Collaboration


Dive into the Mikel Larzabal's collaboration.

Top Co-Authors

Avatar

Luis Bujanda

University of the Basque Country

View shared research outputs
Top Co-Authors

Avatar

Angel Cosme

University of the Basque Country

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juan Arenas

University of the Basque Country

View shared research outputs
Top Co-Authors

Avatar

Elizabeth Hijona

University of the Basque Country

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Inés Gil

University of the Basque Country

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge